| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8243203 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 7 Pages |
Abstract
Conclusion: Percutaneous implantation of this novel 32P brachytherapy device into hepatocellular carcinoma is safe and well tolerated. A significant degree of antitumor efficacy was demonstrated at this low dose that warrants further investigation.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Anthony Soon-Whatt M.D., M.Sc., Alexander Yaw-Fui M.D., Richard Houa-Gong M.D., F.R.C.R., Te-Neng M.D., F.R.C.R., Sidney Wing-Kwong Ph.D., May B.Sc., Somanesan B.Sc. (Hons), Susan Li-Er M.D., Ph.D., David Chee-Eng M.D., Beng-Choo Ph.D., Stephen B.Sc.,